A human plasma derived supplement preserves function of human vascular cells in absence of fetal bovine serum

C. Castells-Sala, J. Martorell, M. Balcells

Producció científica: Article en revista indexadaArticleAvaluat per experts

7 Cites (Scopus)

Resum

Current techniques for cell culture routinely use animal-derived components. Fetal bovine serum (FBS) is the most widely applied supplement, but it often displays significant batch-to-batch variations and is generally not suitable for clinical applications in humans. A robust and xeno-free alternative to FBS is of high interest for cellular therapies, from early in vitro testing to clinical trials in human subjects. In the current work, a highly consistent human plasma derived supplement (SCC) has been tested, as a potential substitute of FBS in primary human vascular cells culture. Our results show that SCC is able to support proliferation, preserve cellular morphology and potentiate functionality analogously to FBS. We conclude that SCC is a viable substitute of FBS for culture and expansion of cells in advanced therapies using human vascular cells and fibroblasts.

Idioma originalAnglès
Número d’article41
RevistaCell and Bioscience
Volum7
Número1
DOIs
Estat de la publicacióPublicada - 2017

Fingerprint

Navegar pels temes de recerca de 'A human plasma derived supplement preserves function of human vascular cells in absence of fetal bovine serum'. Junts formen un fingerprint únic.

Com citar-ho